🔗 Share this article

Given that the US continues making historic changes to its immunization guidelines, a particular individual appears in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports physician and public health researcher who rose to prominence by questioning COVID-19 shots in the pandemic and has focused upon alleged fatalities following Covid immunization in her short position at the US Food and Drug Administration (FDA).

Proposed Shifts to Childhood Vaccine Schedule

Health officials had intended to reveal radical changes to the pediatric vaccine schedule earlier this month, bringing the US with Denmark’s national calendar, sources say – a substantial departure that would put the US at odds with a large portion of the world with no evidence for improved outcomes. The planned update has been pushed back until the new year.

In place of Vinay Prasad, Dr. Høeg is scheduled to address the audience at the gathering. She was newly appointed temporary leader of the FDA’s drug evaluation center, the fifth person to run the center this year.

Consolidating Power at the Regulatory Body

The acting appointment may indicate a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Prasad solidify control at the FDA – and it suggests a renewed priority upon dismantling already-approved vaccines at the FDA.

Dr. Høeg has often pushed for ending certain childhood shot schedules in the US in order to be more like Denmark, a nation with comprehensive healthcare and a number of inhabitants about the size of Wisconsin’s.

In her initial public appearances, she has kept her attention on immunizations – typically the domain of Prasad, head of the FDA’s vaccine center – instead of medication approval.

Questions Over Expertise

Høeg has no apparent background in pharmaceutical research, oversight or management, which has been customary for previous directors of the biologics center. She has been employed at the FDA as a top consultant to the agency head and CBER since earlier this year.

“She appears not to have any of the qualifications” for leading the pharmaceutical oversight division, said a neurologist and psychiatrist. “She’s never run a scientific study. She is not versed in running a sizeable institution. She has no expertise in pharmaceutical oversight.”

Past heads of the center would “understand legal statutes and the research of pharmaceutical innovation”, commented Janet Woodcock. “Objectively, she doesn’t have the kind of background that prior appointees who headed the center have had.”

CDER has an enormous portfolio at the FDA, Woodcock pointed out.

“Many people just focuses on the new drug program, but the generic program approves thousands of generic drugs. There is also a biosimilars program, over-the-counter program and so forth, and every single one have to be supervised,” Woodcock explained. “The responsibility you don’t keep your eye on, that’s the thing that I always told people is going to cause problems.”

Additionally, a substantial administrative component to the role, which supervises more than 5,000 employees. “It’s a huge administrative position, if you execute it properly,” the former official added.

Agency Reaction and Controversial Policies

When asked about questions about Høeg’s credentials and whether this assignment signifies more teamwork among regulatory chiefs on vaccines, a representative stated that the “inquiries are based on flawed presumptions”.

“Her resume aligns with the functions of her role,” the official said, citing the months Dr. Høeg spent counseling the FDA commissioner on “drug safety and oversight research, including computational safety modeling and immunization monitoring”.

As acting director, Dr. Høeg assumes responsibility for the commissioner’s recently launched fast-track approval initiative, a disputed one-day therapy clearance system that allegedly concerned her predecessors. “By what process are these drugs being chosen for this expedited pathway? Who makes the decisions?” Dr. Howard asked. “There’s a lot of secrecy going on at the FDA right now.”

In general, he stated, “the FDA seems to be moving towards more relaxed oversight of pharmaceuticals, aside from shots.”

Public History on Vaccines

Concerning immunizations, Høeg has a clearer, if troubling, past, Howard have noted. She authored a analysis using unconfirmed volunteer-provided data to estimate the frequency of heart inflammation after COVID-19 vaccination. She consulted for the state of Florida chief medical officer Dr. Joseph Ladapo, who allegedly have changed statistics to imply Covid vaccines are pose a greater threat than they are.

Among her “wish list” for the current administration included revising guidelines for novel immunizations and ending “non-essential” vaccines, she said following the vote on a audio program. At the agency, Dr. Høeg has according to sources suggested barring teenage boys from receiving COVID-19 vaccinations.

“She is an all-around ideologue who starts off with her beliefs and works backwards to retrofit the evidence in a very misleading, fraudulent way,” Howard argued.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg aligned with fellow skeptics, {like|